A Study of Pituitary Macroadenoma Transnasal Endoscopic Excision
DOI:
https://doi.org/10.37506/3kdjkb68Keywords:
Pituitary Macroadenoma, Magnetic Resonance Imaging, Transnasal endoscopic excisionAbstract
Background: Pituitary macroadenomas are typically benign tumors over 10mm in size, originating from glandular tissue in the pituitary gland. Understanding tumor consistency is crucial for determining the surgical approach. Imaging, especially MRI, helps assess tumor size, extent, and consistency, which influence the ease of resection, success, and complication risks.
Aim:To study the presentation, radiological evaluation, surgical technique, complication and management of pituitary macroadenoma.
Materials and Methods:This observational study was conducted at a tertiary care hospital in Chennai from March to September 2016, involving 28 patients with pituitary macroadenomas. Data on demographics, tumor type, presentation, consistency (from MRI T2-weighted images), intraoperative findings and complications, along with their management were collected and analyzed using descriptive statistics.
Results:Of the 28 cases, 17(60.7%) were nonsecretory, and 11(39.3%) were secretory. Common symptoms included headaches (71.4%) and visual defects (42.8%). MRI revealed 46.4% of tumors were solid, 35.7% semisolid, and 17.9% cystic, with 50% extending to the suprasellar region. Surgical findings indicated that most solid tumors (92.3%) were firm, 60% of semisolid tumors were soft and 40% were firm , while cystic consistency matched MRI predictions. The most common postoperative complication was diabetes insipidus in 3 cases (10.7%).
Conclusion: Pituitary macroadenomas were most common in the 5th decade. Nonsecretory tumors were more common, particularly in females, while secretory tumors were more prevalent in males. MRI was useful tool in predicting tumor consistency, and the transsphenoidal endoscopic approach was effective for removing cystic and soft macroadenomas.
References
Al-Brahim NY, Asa SL. My approach to pathology of the pituitary gland. J Clin Pathol. 2006 Dec;59(12):1245-53.
Board PA. Pituitary Tumors Treatment (PDQ®). InPDQ Cancer Information Summaries [Internet] 2022 Nov 4. National Cancer Institute (US).
Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: a systematic review. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2004 Aug 1;101(3):613-9.
Haliloglu O, Kuruoglu E, Ozkaya HM, Keskin FE, Gunaldi O, Oz B, et al. Multidisciplinary approach for acromegaly: A single tertiary center’s experience. World Neurosurg 2016;88:270 6.
Gruppetta M, Mercieca C, Vassallo J. Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 2013 Dec;16:545-53.
Bhuyan M, Sarma D, Dutta D, Yadav Y, Das S. Clinicopathological studies of pituitary adenoma in the region of North East India. J Arab Soc Med Res 2016;11:43 9.
Monga K, Gupta V, Gupta S, Marwah K. Clinicopathological study and epidemiological spectrum of brain tumours in Rajasthan. Indian J Basic Appl Med Res 2015;5:728 34
Asa SL. Tumors of the pituitary gland. American registry of pathology; 1998.
Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain Pathol. 2012 Jul;22(4):443-53.
Scangas GA, Laws ER Jr. Pituitary incidentalomas. Pituitary. 2014 Oct;17(5):486-91.
https://radiopaedia.org/articles/pituitary-macroadenoma1?lang=gb]
Wilson CB. Neurosurgical management of large and invasive pituitary tumors. In: Tindall GT, Collins WF, eds. Clinical management of pituitary disorders. New York, NY: Raven, 1979; 335–342.
Fahlbusch R, Buchfelder M. Transsphenoidal surgery of parasellar pituitary adenomas. Acta Neurochir (Wien). 1988;92(1-4):93-9.
Goel A, Nadkarni T, Kobayashi S : Surgical management of giant pituitary tumors, neurosurgery of complex tumors and vascular lesions. Kobayashi S, Goel A, Hongo F (Eds.) Churchill livingstone, New York. 1997; 259-272
Ciric I, Ragin A, Baumgarten PAC et al : Complications of transsphenoidal surgery : Results of a national survey, review of literature and personal experience. Neurosurgery 1997; 40 : 225-237.
Khurana R, Verma M, Swain P, Bhatia V. An audit of over two decades of treating pituitary adenomas at a tertiary care facility. J Radiat Cancer Res 2016;7:117 21.
Russ S, Anastasopoulou C, Shafiq I. Pituitary Adenoma. [Updated 2023 Mar 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554451/.
Gadelha MR, Kasuki L, Korbonits M. The genetic background of acromegaly. Pituitary 2017;20:10 21.
Cawich S, Crandon I, Harding H, MCLENNON H. Clinical presentations of pituitary adenomas at a university hospital in Jamaica. Internet J Family Pract. 2009;7(2). 41
Castro MC, Michel LM, Denaro MM, Gontijo PA, Sousa AA. Endoscopic transnasal approach for removing pituitary tumors. Arq Neuropsiquiatr. 2014 May;72(5):378-82.
Matsuyama J, Kawase T, Yoshida K, Hasegawa M, Hirose Y, Nagahisa S, et al. Management of large and giant pituitary adenomas with suprasellar extensions. Asian J Neurosurg. 2010 Jan;5(1):48-53
Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, et al. Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf). 2012 Jul;77(1):72-8.
Yamamoto J, Kakeda S, Shimajiri S, Takahashi M, Watanabe K, Kai Y, et al. Tumor consistency of pituitary macroadenomas: predictive analysis on the basis of imaging features with contrast-enhanced 3D FIESTA at 3T. AJNR Am J Neuroradiol. 2014 Feb;35(2):297-303.
Ramakrishnan VR, Suh JD, Lee JY, O'Malley BW Jr, Grady MS, Palmer JN. Sphenoid sinus anatomy and suprasellar extension of pituitary tumors. J Neurosurg. 2013 Sep;119(3):669-74.
Ahmadi J, North C M, Segall H D, Zee C S, Weiss M H. Cavernous sinus invasion by pituitary adenomas. AJNR Am J Neuroradiol. 1985;6:893–898
Pan L X, Chen Z P, Liu Y S, Zhao J H. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space. J Neurooncol.2005;74(1):71–76.
Hardy J, Vezina J L. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol. 1976;15:261–273.
Knosp E Steiner E Kitz K Matula C Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findingsNeurosurgery 1993334610–617.617; discussion 617–618
Arbolay OL, Manresa JL, Gálvez YH. Endonasal endoscopic approach in pituitary adenomas: surgical results. Neuroscience Discovery. 2013 Aug 20;1(1):5.
Fan YP, Lv MH, Feng SY, Fan X, Hong HY, Wen WP, et al. Full Endoscopic Transsphenoidal Surgery for Pituitary Adenoma-emphasized on Surgical Skill of Otolaryngologist. Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(Suppl 1):334-40.
Yu SY, Du Q, Yao SY, Zhang KN, Wang J, Zhu Z, et al. Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis. J Cell Mol Med. 2018;22(3):2023–7.
Chandankhede VA, Singh SK, Roy R, Goyal S, Sridhar MS, Gill MS. Transnasal Transsphenoidal Approach for Pituitary Tumors: An ENT Perspective. Indian J Otolaryngol Head Neck Surg. 2020 Jun;72(2):239-246.
Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017 Mar;8(3):33-48.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.